Rethinking Brain Health: What Fibrin, Blood Flow, and Inflammation May Be Telling Us

If you’re concerned about your brain, now is the time to start improving it. Whether you are 20 or going on 80, new research shows that you can continue to improve, not just maintain, your brain health and cognition. At the same time that research is proving that our brains are neuroplastic, we are seeing a rapid increase in brain-related conditions, from cognitive decline to Alzheimer’s, Parkinson’s, and vascular dementia. We’re no longer looking at these conditions through the lens of inevitable aging.  Here is another blog where I discuss enzyme solutions and new research for Alzheimer’s disease.

For years, the conversation centered mostly around amyloid plaques. But in clinical practice and in verified research, it’s becoming clear that brain health is much more interconnected. We’re looking at a web of factors that includes vascular health, inflammation, oxidative stress, and protein accumulation.  

It's About Flow and Quality 

We often think of circulation in terms of “getting enough blood to the brain.” But what’s becoming more relevant is how well that blood is flowing at the micro level.

When fibrinogen levels are elevated, your body becomes more prone to forming thicker, more resistant clots. On its own, that’s already a concern for the limb where you form a clot and for your entire body. How does fibrinogen get elevated? Systemic inflammation causes elevated fibrinogen. What causes systemic inflammation? Everything from high blood sugar to emotional stress can result in inflammation. Every disease state we have a name for has an element of inflammation involved.  

Most worrisome to most people is having a clot in the brain, which can cause a stroke.  When your blood–brain barrier becomes compromised, fibrinogen can actually cross into brain tissue. And once it’s there, it doesn’t just sit quietly.  

It can:

• Activate microglia (the brain’s immune cells)
• Drive neuroinflammation
• Contribute to oxidative stress
• Ultimately impact neuronal health and signaling

So now we’re not just dealing with a vascular issue, we’re looking at a direct contributor to cognitive decline.

The Amyloid–Fibrin Connection

We have all heard the word “amyloid” and know that it is connected to brain health. Β-amyloid is the plaque that is implicated in causing the brain changes in Alzheimer’s disease. B amyloid also interacts with fibrinogen.

When you have both B-amyloid plaque and fibrinogen in your brain, instead of forming normal, easily broken-down clots, this interaction creates denser, more resistant structures. These “sticky” clots don’t clear efficiently and may contribute to microvascular blockages in the brain.

The results of this are:

• Reduced oxygen delivery
• Impaired nutrient flow
• Slower clearance of metabolic waste

And over time, this creates an environment where neurodegeneration can accelerate. You end up with symptoms of cognitive decline or a diagnosis of Alzheimer’s, Parkinsons, or other brain-related diseases.  

When the Cleanup System Slows Down

Under normal conditions, your body has a built-in system to regulate blood flow by breaking down fibrinogen. This process is called fibrinolysis.

This is the process that breaks down fibrin and fibrinogen. Fibrinolysis, breaking down fibrin and fibrinogen, happens because of enzymes. In particular, the tPA (tissue plasminogen activator) is responsible for fibrinolysis.  

But in many neurodegenerative conditions, we see:

• Reduced fibrinolytic activity
• Increased clot persistence
• Accumulation of fibrin and amyloid

But your body can create so much fibrin that your natural enzyme production and fibrinolysis process can’t keep up with the vascular debris. I think of clots like a wad of lemon peels in the garbage disposal.  Your disposal can chew up the lemon peels if you feed them in a little at a time, but if you have too much at once, you stop up the whole system. If you leave lemon peels in the disposal and don’t run the motor, you can get the water to drain, but very slowly.  

This same thing happens in your brain. If your brain’s vascular system gets clogged or stuffed full of debris from fibrin, everything will slow down and eventually stop.  In your brain’s terms, it means a clot or stroke.

The pattern looks like this:

Elevated fibrinogen → increased inflammation and clot formation

Impaired fibrinolysis → reduced clearance of fibrin and amyloid

Vascular dysfunction → compromised nutrient and oxygen delivery (stroke)

Neuroinflammation → progressive cognitive decline

A Closer Look at Enzymatic Support

Avoiding inflammation is the perfect solution for keeping your excellent brain and systemic health.  The only problem is that we live in a world full of pro-inflammatory foods, chemicals, and lifestyles.  So that strategy will only take you so far.  

Supporting your vascular system and blood flow with enzymatic therapies is a logical choice for prevention and maintenance.

Lumbrokinase is a group of enzymes derived from ground earthworms, and it’s been studied for its ability to:

• Break down fibrin efficiently
• Support healthy blood viscosity
• Potentially interact with amyloid structures

In studies, lumbrokinase appears to be fibrin-specific, meaning it targets problematic clot structures without broadly disrupting normal coagulation the way some traditional medications (think Warfarin/Coumadin) agents can.

Even more recent research suggests it may:

• Help regulate tPA activity
• Support the body’s own fibrinolytic pathways
• Improve cognitive and behavioral outcomes in preclinical models

This means that a simple enzyme supplement could potentially support your vascular system and brain health. 

Boluoke is the patented form of lumbrokinase enzyme that has been studied since the 1980s.  Because it is a systemic enzyme, it works throughout your body.  It is known as a fibrinolytic because it favors the breakdown of fibrin.  

Here are some of the other health issues it has been studied for:

The symptoms of long-haul COVID include vascular symptoms that cause fatigue, heart palpitations, and shortness of breath.  This study explains why these patients have excess “stickiness” or fibrin in their bloodstream, which is leading to their symptoms. 

Liver diseases and hepatitis are characterized by high levels of systemic inflammation and elevated fibrinogen. This blog discusses how to use Boluoke to improve blood flow and restore your liver’s ability to detoxify properly. 

Fibrin is a natural part of the healing process from an injury or surgery. But too much fibrin can delay healing and cause excess scar tissue. You can find my blog about using Boluoke for Scars and Fractures here.

Here is a comparison of lumbrokinase and nattokinase. I often get clients asking which one is better or stronger. It's not just my opinion, the research speaks for itself. Check out the studies that show that lumbrokinase found in Boluoke is 300x stronger than nattokinase.

Where This Leaves Us

The emerging research around fibrinogen, fibrinolysis, and enzymes like lumbrokinase is helping expand the conversation about brain health and amyloid.  Instead of asking, how do we get rid of B-amyloid, the real question is how do we prevent it in the first place?  A healthy vascular system should be the focus of prevention.  Check out my articles about how nitric oxide and creatine support prevention and brain health.   For a customized plan for using Boluoke for your brain health, schedule a consult with me, Carly Neubert BA, NC.

References

1. McLarnon, J. G. (2021). A leaky blood–brain barrier to fibrinogen contributes to oxidative damage in Alzheimer's disease. Antioxidants, 11(1), 102. https://www.mdpi.com/2076-3921/11/1/102
2. Chen, Y., Han, L., Zhu, D. S., & Guan, Y. T. (2025). Fibrinogen and neuroinflammation in the neurovascular unit in stroke. Journal of Inflammation Research. https://www.tandfonline.com/doi/10.2147/JIR.S496433
3. Bhattacharjee, P., & Bhattacharyya, D. (2014). An insight into abnormal fibrin clots pathophysiological roles. IntechOpen. https://www.intechopen.com/chapters/46041
4. Verma, M. K., & Pulicherla, K. K. (2011). Lumbrokinase: A potent and stable fibrin-specific plasminogen activator. https://www.academia.edu/download/31949311
5. Metkar, S. K., et al. (2017). Lumbrokinase for degradation of amyloid fibrils. Journal of Applied Biomedicine. https://www.sciencedirect.com/science/article/pii/S1214021X1630206X
6. Metkar, S. K., et al. (2024). Degradation of Aβ1–42 peptide. International Journal of Neuroscience. https://www.tandfonline.com/doi/10.1080/00207454.2022.2089137
7. Huang, C. Y., et al. (2013). Neuroprotective effects of lumbrokinase. Chemical Research in Toxicology. https://pubs.acs.org/doi/10.1021/tx300429s
8. Sukmawan, Y. P. (2020). Lumbrokinase and fibrinogen reduction. https://www.academia.edu/download/86895870/pdf.pdf
9. Zhang, H., et al. (2023). Thrombolysis and stroke research. Nature Communications. https://www.nature.com/articles/s41467-023-35895-5
10. Bohannon, D. G., et al. (2025). Amyloid and neurovascular regulation. Brain Pathology. https://onlinelibrary.wiley.com/doi/10.1111/bpa.13282